Skip to content

WRBY

Warby Parker Inc.

NYSE · USHealthcareMedical - Instruments & Supplies
$24.59-6.89%

Price as of Jul 20, 2026

WRBY growth

Warby Parker Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+12.0%
EBITDA
+97.2%
EBIT
+72.7%
EPS
+109.7%
Free cash flow
-8.3%
Operating cash flow
-2.1%

Forward estimates

Revenue
+18.2%
EBITDA
EPS
+4706.2%

Three-year CAGR

Revenue
+13.4%
EBITDA
+102.4%
EBIT
+82.3%
Net income
+108.0%
EPS
+107.9%
Free cash flow
+144.4%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.